Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR
<p>Abstract</p> <p>Background</p> <p>EGFR mutation is a strong predictive factor of EGFR-TKIs therapy. However, at least 10% of patients with EGFR wild-type are responsive to TKIs, suggesting that other determinants of outcome besides EGFR mutation might exist. We hypothesized that activation of pho...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2012-08-01
|
| Serier: | Journal of Experimental & Clinical Cancer Research |
| Fag: | |
| Online adgang: | http://www.jeccr.com/content/31/1/65 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
